[Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch
S
S
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001785:Blood Gas Monitoring, Transcutaneous; D004334:Drug Administration Schedule; D005260:Female; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation
D005663:Furans; D009257:Nafronyl
Uber den Einsatz von Naftidrofuryl im Stadium III/IV einer peripher arteriellen Verschlusskrankheit.